A carregar...
Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective
Immuno-oncologics (IOs) differ from chemotherapies as they prime the patient’s immune system to attack the tumor, rather than directly destroying cancer cells. The IO mechanism of action leads to durable responses and prolonged survival in some patients. However, providing robust evidence of the lon...
Na minha lista:
| Publicado no: | Journal for ImmunoTherapy of Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Publicado em: |
BMJ Publishing Group
2020-10-01
|
| Acesso em linha: | https://jitc.bmj.com/content/8/2/e000648.full |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|